Related Experiment Video
Updated: Jul 26, 2026

Rat Model of Adhesive Capsulitis of the Shoulder
Published on: September 28, 2018
MicroRNA-26a deficiency attenuates the severity of frozen shoulder in a mouse immobilization model
Yasuhiko Sumimoto1, Yohei Harada1, Dilimulati Yimiti1
1Department of Orthopaedic Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Abstract:
The main pathogenesis of the frozen shoulder is thought to be the inflammation of the intra-articular synovium and subsequent fibrosis of the shoulder joint capsule. However, the molecular pathogenesis of the frozen shoulder is still unknown. A class of noncoding RNAs, microRNAs contribute to various diseases including musculoskeletal diseases. MicroRNA-26a (miR-26a) has been reported to be associated with fibrosis in several organs. This study aims to reveal the role of miR-26a on fibrosis in the shoulder capsule using a frozen shoulder model in miR-26a deficient (miR-26a KO) mice. MiR-26a KO and wild-type (WT) mice were investigated using a frozen shoulder model. The range of motion (ROM) of the shoulder, histopathological changes such as synovitis, and fibrosis-related gene expression in the model mice were evaluated to determine the role of miR-26a. In WT mice, both inflammatory cell infiltration and thickening of the inferior shoulder joint capsule were observed after 1 week of immobilization, and this thickening further progressed over the subsequent 6 weeks. However, the immobilized shoulder in miR-26a KO mice consistently exhibited significantly better ROM compared with WT mice at 1 and 6 weeks, and histological changes were significantly less severe. The expression of inflammation- and fibrosis-related genes was decreased in the miR-26a KO mice compared with WT mice at 1 and 6 weeks. Together, miR-26a deficiency attenuated the severity of frozen shoulder in the immobilization model mouse. The present study suggests that miR-26a has the potential to be a target miRNA for therapeutic approach to frozen shoulder.
Insights
MicroRNA-26a (miR-26a) deficiency significantly reduced frozen shoulder severity in mice by decreasing inflammation and fibrosis. This suggests miR-26a is a potential therapeutic target for frozen shoulder treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Musculoskeletal Research
Background:
- Frozen shoulder pathogenesis involves synovitis and joint capsule fibrosis, but molecular mechanisms remain unclear.
- MicroRNAs, including microRNA-26a (miR-26a), are implicated in various diseases, with miR-26a linked to fibrosis in multiple organs.
Purpose of the Study:
- To investigate the role of miR-26a in shoulder capsule fibrosis using a mouse model of frozen shoulder.
- To evaluate the therapeutic potential of targeting miR-26a for frozen shoulder.
Main Methods:
- Comparison of range of motion (ROM), histopathological changes (synovitis, fibrosis), and gene expression in immobilized wild-type (WT) and miR-26a deficient (miR-26a KO) mice.
- Utilized an immobilization-induced frozen shoulder model in mice.
Main Results:
- miR-26a KO mice demonstrated significantly better shoulder ROM and reduced histological severity compared to WT mice.
- Inflammation- and fibrosis-related gene expression was notably decreased in miR-26a KO mice.
- Immobilization led to synovitis and joint capsule thickening in WT mice, which was attenuated in miR-26a KO mice.
Conclusions:
- miR-26a deficiency ameliorates frozen shoulder development in an immobilization model.
- miR-26a plays a significant role in the pathogenesis of frozen shoulder.
- miR-26a represents a promising miRNA target for developing novel therapeutic strategies for frozen shoulder.
Related Concept Videos
MicroRNAs
MicroRNAs

